Abionic

Abionic is a scale-up specializing in nanotechnology for diagnostic tests. It has developed biosensors that allow to detect sepsis on a drop of blood in 5 minutes. Current methods take 24 to 72 hours. The early detection of sepsis, a condition that develops as a result of a bacterial infection, saves lives. Every year, 11 million people die because of septic shock.
Nicolas Durand about VERVE Ventures
VERVE Ventures has helped Abionic in many key challenges ranging from fundraising to marketing related issues. Having Verve Ventures as a shareholder is a must have in the Swiss startup ecosystem.
Founders / Management Nicolas Durand, Iwan Märki
Sectors Health & Bio, Biotechnology, Diagnostics
Located in Lausanne
Co-Investors Zürcher Kantonalbank
Follow On

LinkedIn

I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Sign up to receive our weekly newsletter and learn about investing in technologies that are changing the world.